This study focuses on treating chemotherapy-induced fever in adult patients with hematological disorders such as lymphoma, myelodysplasia, and acute myeloblastic leukemia. The purpose is to compare two different antibiotic treatments in patients who develop fever after receiving chemotherapy. The treatments being studied are amoxicillin-clavulanate alone versus a combination of amoxicillin-clavulanate with ciprofloxacin.
The study examines how well these antibiotic treatments work in patients who can receive care outside the hospital. The medications are taken by mouth, and the treatment period lasts for 7 days. During this time, patients will be monitored to see if their fever goes away and if they experience any other health issues.
Patients will be followed for 30 days after starting treatment. The main focus is to determine if using amoxicillin-clavulanate alone works as effectively as using it together with ciprofloxacin. The study will track various aspects of patient health, including whether the fever returns, if hospital admission becomes necessary, and any side effects from the medications.



France